Menactra is a conjugate vaccine developed by Sanofi to provide active immunization against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. The vaccine contains meningococcal polysaccharides conjugated to diphtheria toxoid protein, which enhances the immune response and ensures long-lasting protection. It is administered via intramuscular injection and is suitable for children, adolescents, and adults as per recommended guidelines. Meningococcal disease can lead to life-threatening conditions such as meningitis and septicemia. Menactra plays a vital role in prevention, especially in high-risk populations, travelers to endemic regions, and outbreak control. It is a safe and effective option widely used in immunization programs across the globe.
Specifications
- Service at Doorstep : FREE Home vaccination availability
- Cold Chain Compliance : Maintains 2-8°C
- VACCINATION KIT : AVAILABLE
- VACCINATION OFFICER : YES